Internal Medicine, Rheumatology · Northport, AL
NPI
1174507800
Since 2005
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
4280 Watermelon Rd Ste 112
Northport, AL, 35473
Phone (205) 750-0030
Groups this clinician bills Medicare through
Medicare paid, 2024
$4.2M
298,925 services
Medicare patients, 2024
882
Average age 71
Drug cost, 2024
$9.0M
6,239 prescriptions
Company payments, 2025
$4,096
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Richard E Jones III was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 90,400 times for 37 patients. In total Richard E Jones III billed 298,925 services in 94 codes, and Medicare paid $4.2M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-01-20.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 90,400 | 37 | $3.59 | $325K |
| J3262 Injection, tocilizumab, 1 mg | Office | 87,024 | 18 | $4.70 | $409K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 21,250 | 39 | $33.77 | $718K |
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 18,480 | 20 | $8.51 | $157K |
| J0897 Injection, denosumab, 1 mg | Office | 18,420 | 202 | $20.15 | $371K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 10,830 | 27 | $24.46 | $265K |
| J9312 Injection, rituximab, 10 mg | Office | 6,450 | 23 | $61.18 | $395K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 5,460 | 46 | $0.23 | $1,246 |
| 80053 Clinical Chemistry | Office | 1,299 | 628 | $10.17 | $13K |
| 99214 Office E&M - Established | Office | 1,272 | 668 | $83.96 | $107K |
| 85025 Blood Count | Office | 1,091 | 483 | $7.48 | $8,165 |
| 86140 Clinical Chemistry | Office | 1,085 | 477 | $5.00 | $5,427 |
| 85651 Clinical Chemistry | Office | 1,084 | 476 | $4.11 | $4,460 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,076 | 638 | $11.94 | $13K |
| 96372 Injection Administration | Office | 952 | 264 | $10.42 | $9,922 |
By year: 2022 $5.1M for 416,924 services; 2023 $4.5M for 360,720 services; 2024 $4.2M for 298,925 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80053 Clinical Chemistry | 1,299 | 628 | $10.17 | $13K |
| 85025 Blood Count | 1,091 | 483 | $7.48 | $8,165 |
| 86140 Clinical Chemistry | 1,085 | 477 | $5.00 | $5,427 |
| 85651 Clinical Chemistry | 1,084 | 476 | $4.11 | $4,460 |
| 36415 Venipuncture Blood Collection | 588 | 454 | $8.56 | $5,035 |
| 82306 Clinical Chemistry | 239 | 202 | $28.60 | $6,837 |
| 86481 Immunoassay | 238 | 223 | $96.47 | $23K |
| 86160 Immunoassay | 238 | 54 | $11.25 | $2,676 |
| 84550 Clinical Chemistry | 137 | 59 | $4.35 | $596 |
| 81003 Clinical Chemistry | 131 | 64 | $2.13 | $279 |
Medicare prescription drug claims, 2024
In 2024, the drug Richard E Jones III prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 927 prescriptions and refills. In total Richard E Jones III wrote 6,239 Medicare prescriptions that cost $9.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 927 | 1,354 | 258 | $39K |
| Prednisone Generic | 680 | 940 | 195 | $3,776 |
| Methotrexate Methotrexate Sodium | 622 | 853 | 178 | $13K |
| Tramadol Hcl Generic | 359 | 361 | 60 | $3,943 |
| Gabapentin Generic | 337 | 397 | 57 | $3,373 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 303 | 303 | 35 | $4,706 |
| Allopurinol Generic | 190 | 330 | 59 | $2,684 |
| Diclofenac Sodium Generic | 133 | 172 | 52 | $4,323 |
| Methylprednisolone Generic | 132 | 161 | 60 | $2,166 |
| Tizanidine Hcl Generic | 127 | 191 | 49 | $1,628 |
| Enbrel Sureclick Etanercept | 117 | 117 | 12 | $863K |
| Humira(Cf) Pen Adalimumab | 114 | 119 | 16 | $971K |
| Duloxetine Hcl Generic | 99 | 195 | 35 | $3,702 |
| Ibandronate Sodium Generic | 94 | 237 | 31 | $3,053 |
| Cyclobenzaprine Hcl Generic | 87 | 122 | 27 | $560 |
Brand drugs: 1,107 claims; generic drugs: 5,132 claims; opioid claims: 745.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Richard E Jones III $4,096 ($4,096 in general payments such as food, travel and fees) from 20 companies. The largest payer was Amgen Inc. with $721.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 29 | $721 |
| Abbvie Inc. ABBV | 27 | $534 |
| Aurinia Pharma U.S., Inc. AUPH | 7 | $356 |
| UCB, Inc. UCB.BR | 19 | $353 |
| Mallinckrodt Hospital Products Inc. | 11 | $346 |
| Novartis Pharmaceuticals Corporation NVS | 11 | $254 |
| Janssen Biotech, Inc. JNJ | 9 | $230 |
| GlaxoSmithKline, LLC. GSK | 9 | $229 |
| Genzyme Corporation SNY | 6 | $226 |
| ANI Pharmaceuticals, Inc. ANIP | 5 | $158 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.